A Safety Study of GSK3039294 in Healthy Volunteers and Patients With Systemic Amyloidosis
Clinical trial NCT02603172 · TERMINATED
Trial details
- NCT number
- NCT02603172
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-12
- Primary completion
- 2017-05-10
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.